Literature DB >> 31864918

Evaluating the impact of Georgia's hepatitis C elimination plan: lessons learned for the global initiative.

Yvan Hutin1, Niklas Luhmann2, Philippa Easterbrook2.   

Abstract

Entities:  

Mesh：

Year:  2019        PMID： 31864918     DOI： 10.1016/S2214-109X(19)30537-6

Source DB:  PubMed          Journal:  Lancet Glob Health        ISSN： 2214-109X            Impact factor:   26.763


× No keyword cloud information.
  3 in total

1.  Diagnostic Performance and Usability of the Genedrive® HCV ID Kit in Two Decentralized Settings in Cameroon and Georgia.

Authors:  Francois M J Lamoury; Richard Njouom; Marie Amougou-Atsama; Euloge Yiagnigni Mfopou; Nino Berishvili; Manana Sologashvili; Emmanuel Fajardo; Agnes Malobela; Aurélien Macé; Maxwell Chirehwa; Maia Alkhazashvili; Elena Ivanova Reipold
Journal:  Diagnostics (Basel)       Date:  2021-04-22

2.  Eliminating hepatitis C from countries with high prevalence: When infrastructure comes first.

Authors:  Gamal Esmat; Mohamed El Kassas
Journal:  Indian J Med Res       Date:  2021-07       Impact factor: 2.375

3.  Assessing cost-effectiveness of hepatitis C testing pathways in Georgia using the Hep C Testing Calculator.

Authors:  Madeline Adee; Yueran Zhuo; Huaiyang Zhong; Tiannan Zhan; Rakesh Aggarwal; Sonjelle Shilton; Jagpreet Chhatwal
Journal:  Sci Rep       Date:  2021-11-01       Impact factor: 4.379
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.